Overdose Deaths Surge Among Australians Over 50, Driven by Prescription Drug Combinations
核心洞察
Australians aged 50–59 now account for the highest proportion of unintentional drug-related deaths (25.5%) for the first time in a decade, according to the Penington Institute (搜索).
Prescription opioids (搜索) contribute to nearly half of all unintentional overdoses, and more than 70% of unintentional deaths involve two or more drug types.
Age-related physiological changes reduce the body's ability to metabolize drugs, meaning doses tolerated at 40 can have stronger effects at 60.
For the first time in a decade, Australians aged 50–59 have surpassed all other age groups in unintentional drug-related deaths, according to the latest figures from the Penington Institute (搜索). On average, seven people die every day from a drug-related overdose in Australia, with unintentional overdoses accounting for more than 80% of those fatalities. People aged 50–59 now represent 25.5% of unintentional deaths, closely followed by those aged 40–49 at 25.4%. The same 50–59 cohort also recorded the second-highest rate of intentional drug-related deaths at 19.9%, behind only people in their 70s at 22%.
The data challenge long-held assumptions that overdose primarily affects younger people using illicit street drugs. Instead, the findings reveal a more complex picture in which prescription medicines, ageing physiology, and fragmented healthcare converge to place older Australians at heightened risk.
Prescription medicines drive the burden
Prescription opioids (搜索) remain the most common drug type involved in overdose deaths, contributing to almost half of all unintentional drug overdoses. Commonly recognized agents such as oxycodone, codeine, and tramadol feature prominently. Benzodiazepines (搜索) — including diazepam (Valium), alprazolam (Xanax), and flunitrazepam (Rohypnol) — also play a major role.
When opioids (搜索) and benzodiazepines (搜索) are combined, the consequences can be lethal. More than 70% of unintentional deaths involve two or more types of drugs. Nearly 20% of unintentional drug-induced deaths involved alcohol, and while this figure represents a decrease from previous years, other data indicate that risky alcohol use is rising among women in midlife, which could elevate future risk.
Older adults are over-represented in deaths involving pharmaceutical drugs obtained legally through the healthcare system. Australians over 50 are more likely to have multiple health conditions requiring medication — including chronic pain, insomnia, anxiety, and depression — and many see different prescribers for each condition. This fragmentation can lead to unpredictable drug interactions if not carefully managed.
The ageing body and drug metabolism
Ageing fundamentally alters how the body processes drugs. Declining liver and kidney function reduces the efficiency with which medicines are broken down and eliminated. Lower muscle mass and shifts in body composition further affect pharmacokinetics. As Nicole Lee, Adjunct Professor at the National Drug Research Institute, Curtin University, and Katinka van de Ven, alcohol and other drug specialist at UNSW Sydney, note: "The same dose that was tolerated at 40 may have a stronger effect at 60."
An ageing cohort of people who use illicit drugs
Illicit drug use, while more common among younger adults, has not disappeared with age. People now in their 40s and 50s came of age during the 1980s and 1990s, when Australia experienced relatively high levels of heroin, amphetamine, and cannabis use. While many reduced or stopped using drugs as they aged, a smaller group continued, contributing to an ageing cohort of people who use drugs. Cannabis remains the most commonly used illicit drug among older Australians, but non-medical use of pharmaceutical opioids (搜索) also adds to the burden of harm.
The gap between younger and older people using illicit drugs has narrowed over time. Rates among younger people have remained relatively stable or declined slightly, while rates among those aged 50 and over have increased. There is also limited evidence of "late onset" illicit drug use, with some people in their 40s and 50s using drugs for the first time or returning after a long break. Life transitions such as retirement, bereavement, loneliness, and declining physical health can increase vulnerability, and some individuals may self-medicate with illicit drugs rather than consulting a doctor.
Longer lives, persistent risks
People who use illicit drugs are living longer, benefiting from advances in hepatitis C and HIV treatment, as well as improved access to harm-reduction options including naloxone, needle syringe programs, medically supervised injecting facilities, and opioid agonist treatments such as methadone and buprenorphine. While these developments represent genuine public health progress, they also mean that more individuals are ageing with ongoing drug use and its associated risks.
Stigma and screening gaps
Older people are less likely to be screened for alcohol and other drug problems. Health professionals often overlook substance use in people in their 50s because they do not expect to see it. Stigma compounds the issue: an older person with signs of medication dependence may not identify with traditional drug treatment services and may fear judgment or loss of independence if they disclose drug use to a health professional or family member. As a result, people over 50 more easily fall through the cracks.
Rethinking prevention
The growing number of overdose deaths among Australians in their 50s underscores the need to broaden prevention strategies beyond illicit drugs and younger age groups. Experts call for safer use of medicines and more cautious prescribing practices, improved communication between doctors and patients to identify risky drug combinations, and reduced stigma to enable open conversations about alcohol and other drug use at every age. "If we want to prevent these deaths, we need to recognise that drug-related harm does not disappear with age," Lee and van de Ven write. "It may just change shape. And so must our responses."